{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Foral-serds-for-mbc-g7M97D7w","width":444,"version":"1.0","type":"rich","title":"Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/86952976-b928-4317-884c-2c7ba3b2ae4d/e2919f33-d77e-4ffc-b50b-e00f91e21473/7126-breast-serds-adherence-bc-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/a090a14f-246b-49da-b4a0-6d68f89dd7f4\" height=\"200\" width=\"100%\" title=\"Experiences With Oral SERDs for HR+/HER2- Metastatic Breast Cancer\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen as a medical oncologist, pharmacist, and nurse practitioner discuss their experiences with oral SERDs for the treatment of hormone receptor–positive, HER2-negative, metastatic breast cancer, including how to manage adverse events and ways to promote treatment adherence and persistence."}